Evaluate the Efficacy and Safety of DWJ108J

Clinical trial NCT06025409 · UNKNOWN

Trial details

NCT number: NCT06025409
Sponsor: Daewoong Pharmaceutical Co. LTD.
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Central Precocious Puberty

Start date: 2023-08-01
Primary completion: 2025-02-28
Enrollment: 79

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.